Abstract:Abstract 14-3-3ζ overexpression in breast cancer is associated with accelerated cancer progression and poor clinical outcome in patients. Our previous study revealed that 14-3-3ζ overexpression promotes epithelial mesenchymal transition (EMT) of breast cancer cells, which facilitates progression of ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC). However, the impact of 14-3-3ζ overexpressing breast cancer cells on tumor microenvironment (TME) and the underlying mechanisms have not been explored. We found dramatically increased cancer associated fibroblast (CAF) signatures in patients' matched IDC lesions compared to their DCIS lesions, suggesting that activated fibroblasts may be involved in DCIS to IDC transition. Global gene expression profiling uncovered increased expression of pro-inflammatory cytokines/chemokines, including IL6 and IL8, in 14-3-3ζ AND ErbB2 co-overexpressed 10A.ErbB2.1433ζ cells compared to ErbB2 overexpressed 10A.ErbB2 cells. This finding was further confirmed by ELISA and validated in other breast cancer cell lines. We tested whether increased pro-inflammatory cytokines in the conditional medium (CM) from 14-3-3ζ overexpressed cancer cells promotes CAF-like phenotype. Indeed, CM from 14-3-3ζ overexpressed cancer cells significantly increased SMA+ activated fibroblast cells compared to controls. Additionally, up-regulation of β-galactosidase and reduced cell proliferation, hallmarks of senescence cells, were detected in fibroblast cells cultured in CM from 14-3-3ζ overexpressed cancer cells. Next, we explored potential mechanism of how 14-3-3ζ overexpression in cancer cells leads to up-regulation of pro-inflammatory cytokines/chemokines. Since NF-kappaB is one of the master upstream regulator of IL-6 and IL-8, we next investigated the NF-kappaB signaling activation in 14-3-3ζ overexpressed vs control cancer cells. 14-3-3ζ overexpressing cancer cells had hyperactive canonical NF-kappaB responses, including accelerated IκBα degradation, p65 phosphorylation, as well as nuclear translocation compared to 14-3-3ζ low cancer cells. Prolonged NF-kappaB signaling activation upon pro-inflammatory cytokine stimulation was also detected in 14-3-3ζ overexpressing cancer cells. These results suggest that 14-3-3ζ overexpressing cancer cells may promote fibroblast cell senescence and CAF-like phenotype by creating by a chronic inflammatory microenvironment, which ultimately enhances DCIS to IDC transition. Citation Format: Hongzhong Li, Yi Xiao, Xiangliang Yuan, Wenling Kuo, Ping Li, Dihua Yu. 14-3-3zeta overexpressing breast cancer cells promote fibroblast senescence and CAF-like phenotype [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 59.

Data from 14-3-3ζ Down-regulates P53 in Mammary Epithelial Cells and Confers Luminal Filling

Data from Genetic Ablation of <i>rbm38</i> Promotes Lymphomagenesis in the Context of Mutant P53 by Downregulating PTEN

Abstract 830: ZFP14, a p53 target, suppresses tumor formation by regulating HOXA gene cluster expression

Data from 14-3-3ζ Overexpression Defines High Risk for Breast Cancer Recurrence and Promotes Cancer Cell Survival

Abstract 59: 14-3-3zeta Overexpressing Breast Cancer Cells Promote Fibroblast Senescence and CAF-like Phenotype

Tumor suppressor FRMD3 controls mammary epithelial cell fate determination via notch signaling pathway

Induction of P53 Expression and Apoptosis by a Recombinant Dual-Target MDM2/MDMX Inhibitory Protein in Wild-Type P53 Breast Cancer Cells.

TP53 Supports Basal-Like Differentiation of Mammary Epithelial Cells by Preventing Translocation of Deltanp63 into Nucleoli

14-3-3 Zeta Overexpression Defines High Risk For Breast Cancer Recurrence And Promotes Cancer Cell Survival

Abstract 5427: Increased glycolysis by 14-3-3ζ-mediated LDHA up-regulation contributes to transformation of early mammary epithelial cells.

Upregulation Of Lactate Dehydrogenase A By 14-3-3 Zeta Leads To Increased Glycolysis Critical For Breast Cancer Initiation And Progression

A role for p53 in the regulation of extracellular matrix metalloproteinase inducer in human cancer cells.

Snail1-dependent P53 Repression Regulates Expansion and Activity of Tumour-Initiating Cells in Breast Cancer

Transcriptional Regulation of Estrogen Receptor-Alpha by P53 in Human Breast Cancer Cells

Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway

Regulation of P53 signaling in breast cancer by the E3 ubiquitin ligase RNF187

Abstract 987: Overexpression of 14-3-3α in cancer cells activates PI3K via binding the p85 regulatory subunit

A ZEB1/p53 Signaling Axis in Stromal Fibroblasts Promotes Mammary Epithelial Tumours

Downregulation of Wild-Type P53 Protein by HER-2/neu Mediated PI3K Pathway Activation in Human Breast Cancer Cells: Its Effect on Cell Proliferation and Implication for Therapy

Mutant P53 Induces EZH2 Expression and Promotes Epithelial-Mesenchymal Transition by Disrupting P68-Drosha Complex Assembly and Attenuating Mir-26A Processing